B. Braun: 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container
Presence of particulate matter identified as iron oxide
Not suppliedPublished notice; closure not supplied
Distribution: Not supplied
Home / Brand archive
240 reported ongoing
258 records in this archive. Latest source date Sep 3, 2026. 4 published notices do not supply a closure status.
FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
Presence of particulate matter identified as iron oxide
Not suppliedPublished notice; closure not supplied
Distribution: Not supplied
Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene
Class IReported ongoing
Distribution: Nationwide within the United States
Presence of Particulate matter.
Class IReported ongoing
Distribution: U.S. Nationwide
Specific lots of Discofix Stopcock Sets recalled due to an incorrect expiration date printed on the carton shipper label.
Class IIReported ongoing
Distribution: Worldwide - US Nationwide distribution in the states of CA, CO, FL, GA, HI, IL, IN, LA, MA, MD, NC, NJ, NY, PA, TN, TX, VA, WA the country of Canada.
These procedure kits contain Bupivacaine Hydrochloride in Dextrose Injection, USP. The manufacturer of the Bupivacaine, Huons Co, Ltd., has issued a voluntary recall due to potential quality issues identified during a recent FDA manufacturing facility inspe...
Class IReported ongoing
Distribution: US Nationwide distribution.
These procedure kits contain Bupivacaine Hydrochloride in Dextrose Injection, USP. The manufacturer of the Bupivacaine, Huons Co, Ltd., has issued a voluntary recall due to potential quality issues identified during a recent FDA manufacturing facility inspe...
Class IReported ongoing
Distribution: US Nationwide distribution.
These procedure kits contain Bupivacaine Hydrochloride in Dextrose Injection, USP. The manufacturer of the Bupivacaine, Huons Co, Ltd., has issued a voluntary recall due to potential quality issues identified during a recent FDA manufacturing facility inspe...
Class IReported ongoing
Distribution: US Nationwide distribution.
Presence of Particulate Matter.
Class IReported ongoing
Distribution: U.S.A. Nationwide
Products were found to contain particulate matter in solution
Not suppliedPublished notice; closure not supplied
Distribution: The product can be identified by product code E7500 or NDC 0264-7750-07. Product was distributed Nationwide to distributors, hospital, and healthcare facilities.
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Class IIReported ongoing
Distribution: US Nationwide.
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Class IIReported ongoing
Distribution: US Nationwide.
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Class IIReported ongoing
Distribution: US Nationwide.
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Class IIReported ongoing
Distribution: US Nationwide.
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
Class IReported ongoing
Distribution: Worldwide distribution - US Nationwide and the country of Canada.
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
Class IReported ongoing
Distribution: Worldwide distribution - US Nationwide and the country of Canada.
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
Class IReported ongoing
Distribution: Worldwide distribution - US Nationwide and the country of Canada.
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
Class IReported ongoing
Distribution: Worldwide distribution - US Nationwide and the country of Canada.
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
Class IReported ongoing
Distribution: Worldwide distribution - US Nationwide and the country of Canada.
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
Class IReported ongoing
Distribution: Worldwide distribution - US Nationwide and the country of Canada.
The potential for the needle tip to be dull/blunt, difficult to advance, and/or break.
Class IIReported ongoing
Distribution: Worldwide - US Nationwide distribution in the state of TX and the country of Costa Rica.
These examples come from this result page and are not a ranking of every recall reason.
This archive contains 258 records, including 240 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.